Because ANCOR has long advocated that the Food and Drug Administration (FDA) ban electric shock devices used on children and adults with I/DD, we are sharing this item from Politico Pulse on the agency’s leadership:
“STEPHEN HAHN’s nomination to lead FDA is imminent. Hahn, a radiation oncologist at MD Anderson Cancer Center in Houston, is the selection for the role pending clearance of a background check, multiple sources told POLITICO in September. A federal deadline is looming Nov. 1.”
Stay Informed on the Latest Research & Analysis from ANCOR